Tenax Therapeutics Inc Cash Flow-to-Debt Ratio
Tenax Therapeutics Inc cash flow-to-debt ratio. Tenax Therapeutics Inc (TENX) has a Cash Flow-to-Debt Ratio of -1.75x as of June 2026, meaning its operating cash flow of $-14.15 Million could theoretically repay -2% of its total liabilities ($8.07 Million) in one year. Check how high is Tenax Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tenax Therapeutics Inc (1995–2025)
Cash flow-to-debt ratio of Tenax Therapeutics Inc from 1995 to 2025. Historical debt coverage capacity for Tenax Therapeutics Inc across 31 annual periods. Also explore Tenax Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Tenax Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1995–2025)
Tenax Therapeutics Inc cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Tenax Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Tenax Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.00x | $-35.80 Million | $7.16 Million | ▼ -58.5% |
| 2024 | -3.16x | $-14.81 Million | $4.69 Million | ▼ -91.7% |
| 2023 | -1.65x | $-5.90 Million | $3.59 Million | ▲ +73.8% |
| 2022 | -6.28x | $-12.01 Million | $1.91 Million | ▼ -1.1% |
| 2021 | -6.21x | $-10.86 Million | $1.75 Million | ▼ -50.3% |
| 2020 | -4.13x | $-9.27 Million | $2.24 Million | ▼ -41.8% |
| 2019 | -2.91x | $-7.56 Million | $2.59 Million | ▲ +17.0% |
| 2018 | -3.51x | $-5.50 Million | $1.57 Million | ▲ +70.8% |
| 2017 | -12.03x | $-12.14 Million | $1.01 Million | ▼ -370.0% |
| 2016 | -2.56x | $-15.87 Million | $6.20 Million | ▼ -229.9% |
| 2015 | -0.78x | $-9.75 Million | $12.56 Million | ▲ +11.7% |
| 2014 | -0.88x | $-9.26 Million | $10.54 Million | ▲ +0.0% |
| 2013 | -0.88x | $-9.26 Million | $10.54 Million | ▲ +35.1% |
| 2012 | -1.35x | $-4.92 Million | $3.64 Million | ▼ -8.9% |
| 2011 | -1.24x | $-8.40 Million | $6.76 Million | ▲ +79.7% |
| 2010 | -6.12x | $-8.59 Million | $1.40 Million | ▼ -81.0% |
| 2009 | -3.38x | $-4.06 Million | $1.20 Million | ▼ -166.5% |
| 2008 | -1.27x | $-2.28 Million | $1.79 Million | ▼ -174.6% |
| 2007 | -0.46x | $-1.14 Million | $2.46 Million | ▲ +90.9% |
| 2006 | -5.06x | $-2.15 Million | $424.57K | ▲ +20.3% |
| 2005 | -6.34x | $-1.99 Million | $313.94K | ▼ -29.3% |
| 2004 | -4.91x | $-1.77 Million | $361.51K | ▲ +21.8% |
| 2003 | -6.27x | $-2.09 Million | $333.75K | ▲ +73.0% |
| 2002 | -23.27x | $-1.90 Million | $81.55K | ▼ -502.6% |
| 2001 | -3.86x | $-1.54 Million | $398.09K | ▼ -46.1% |
| 2000 | -2.64x | $-913.30K | $345.44K | ▼ -98.3% |
| 1999 | -1.33x | $-800.00K | $600.00K | ▼ -46.9% |
| 1998 | -0.91x | $-575.69K | $634.36K | ▲ +37.5% |
| 1997 | -1.45x | $-872.15K | $600.67K | ▲ +5.9% |
| 1996 | -1.54x | $-1.53 Million | $991.54K | ▲ +0.0% |
| 1995 | -1.54x | $-1.53 Million | $991.54K | — |